Methodological quality and reporting of ethical requirements in clinical trials

Objectives—To assess the relationship between the approval of trials by a research ethics committee (REC) and the fact that informed consent from participants (ICP) was obtained, with the quality of study design and methods. Design—Systematic review using a standardised checklist. Main measures—Met...

Full description

Bibliographic Details
Main Authors: Ruiz-Canela, M. (Miguel), Irala, J. (Jokin) de, Martinez-Gonzalez, M.A. (Miguel Ángel), Gomez-Gracia, E. (Enrique), Fernandez-Crehuet, J. (Joaquín)
Format: info:eu-repo/semantics/article
Language:eng
Published: BMJ Publishing Group 2010
Subjects:
Online Access:https://hdl.handle.net/10171/6971
_version_ 1793400166247563264
author Ruiz-Canela, M. (Miguel)
Irala, J. (Jokin) de
Martinez-Gonzalez, M.A. (Miguel Ángel)
Gomez-Gracia, E. (Enrique)
Fernandez-Crehuet, J. (Joaquín)
author_facet Ruiz-Canela, M. (Miguel)
Irala, J. (Jokin) de
Martinez-Gonzalez, M.A. (Miguel Ángel)
Gomez-Gracia, E. (Enrique)
Fernandez-Crehuet, J. (Joaquín)
author_sort Ruiz-Canela, M. (Miguel)
collection DSpace
description Objectives—To assess the relationship between the approval of trials by a research ethics committee (REC) and the fact that informed consent from participants (ICP) was obtained, with the quality of study design and methods. Design—Systematic review using a standardised checklist. Main measures—Methodological and ethical issues of all trials published between 1993 and 1995 in the New England Journal of Medicine, the Lancet, the Journal of the American Medical Association and the British Medical Journal were studied. In addition, clinical trials conducted in Spain and published by at least one Spanish author during the same period in any other journal were also included. Results—We studied the published articles of 767 trials and found the following indicators of lower methodological quality to be independent predictors for failure to disclose REC approval or ICP: absence of concealment of allocation, lack of justification for unblinded trials, not using a treatment for the patients in the control group, absent information on statistical methods, not including sample size estimation, not establishing the rules to stop the trial, and omitting the presentation of a baseline comparison of groups Conclusion—Trials of higher methodological and scientific quality were more likely to provide information about their ethical aspects.
format info:eu-repo/semantics/article
id oai:dadun.unav.edu:10171-6971
institution Universidad de Navarra
language eng
publishDate 2010
publisher BMJ Publishing Group
record_format dspace
spelling oai:dadun.unav.edu:10171-69712022-06-29T09:41:38Z Methodological quality and reporting of ethical requirements in clinical trials Ruiz-Canela, M. (Miguel) Irala, J. (Jokin) de Martinez-Gonzalez, M.A. (Miguel Ángel) Gomez-Gracia, E. (Enrique) Fernandez-Crehuet, J. (Joaquín) Materias Investigacion::Ciencias de la Salud::Enseñanza médica, formación e investigación Objectives—To assess the relationship between the approval of trials by a research ethics committee (REC) and the fact that informed consent from participants (ICP) was obtained, with the quality of study design and methods. Design—Systematic review using a standardised checklist. Main measures—Methodological and ethical issues of all trials published between 1993 and 1995 in the New England Journal of Medicine, the Lancet, the Journal of the American Medical Association and the British Medical Journal were studied. In addition, clinical trials conducted in Spain and published by at least one Spanish author during the same period in any other journal were also included. Results—We studied the published articles of 767 trials and found the following indicators of lower methodological quality to be independent predictors for failure to disclose REC approval or ICP: absence of concealment of allocation, lack of justification for unblinded trials, not using a treatment for the patients in the control group, absent information on statistical methods, not including sample size estimation, not establishing the rules to stop the trial, and omitting the presentation of a baseline comparison of groups Conclusion—Trials of higher methodological and scientific quality were more likely to provide information about their ethical aspects. 2010-04-28T07:56:49Z 2010-04-28T07:56:49Z 2001 info:eu-repo/semantics/article https://hdl.handle.net/10171/6971 eng http://jme.bmj.com/content/27/3/172.full info:eu-repo/semantics/openAccess application/pdf BMJ Publishing Group
spellingShingle Materias Investigacion::Ciencias de la Salud::Enseñanza médica, formación e investigación
Ruiz-Canela, M. (Miguel)
Irala, J. (Jokin) de
Martinez-Gonzalez, M.A. (Miguel Ángel)
Gomez-Gracia, E. (Enrique)
Fernandez-Crehuet, J. (Joaquín)
Methodological quality and reporting of ethical requirements in clinical trials
title Methodological quality and reporting of ethical requirements in clinical trials
title_full Methodological quality and reporting of ethical requirements in clinical trials
title_fullStr Methodological quality and reporting of ethical requirements in clinical trials
title_full_unstemmed Methodological quality and reporting of ethical requirements in clinical trials
title_short Methodological quality and reporting of ethical requirements in clinical trials
title_sort methodological quality and reporting of ethical requirements in clinical trials
topic Materias Investigacion::Ciencias de la Salud::Enseñanza médica, formación e investigación
url https://hdl.handle.net/10171/6971
work_keys_str_mv AT ruizcanelammiguel methodologicalqualityandreportingofethicalrequirementsinclinicaltrials
AT iralajjokinde methodologicalqualityandreportingofethicalrequirementsinclinicaltrials
AT martinezgonzalezmamiguelangel methodologicalqualityandreportingofethicalrequirementsinclinicaltrials
AT gomezgraciaeenrique methodologicalqualityandreportingofethicalrequirementsinclinicaltrials
AT fernandezcrehuetjjoaquin methodologicalqualityandreportingofethicalrequirementsinclinicaltrials